Stock KTTA PASITHEA THERAPEUTICS CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Pasithea Therapeutics Corp.

Equities

KTTA

US70261F2020

Market Closed - Nasdaq
Other stock markets
 04:30:01 2024-05-09 pm EDT 		5-day change 1st Jan Change
7.68 USD +8.93% Intraday chart for Pasithea Therapeutics Corp. +10.98% +3.78%
Apr. 24 Pasithea Therapeutics Corp. Announces the First Cohort Has Completed the Initial Dosing in Its Phase 1 Trial Evaluating Pas-004 in Ras, Nf1 and Raf Mutated Cancers CI
Mar. 29 Pasithea Therapeutics Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
PASITHEA THERAPEUTICS CORP.
Bio Therapeutic Drugs
+8.93%+10.98%+3.78%+6.40% - 8.01M
Neutral
Neutral
Bearish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. KTTA Stock
  4. Charts Pasithea Therapeutics Corp.
  5. Comparison Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW